Skip to main content

Table 2 Concentration of plasma SCFAs in healthy controls and patients with MASLD

From: Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease

SCFA, µmol/L

Healthy controls

N = 50

MASLD

N = 100

Acetate

57.6 (25.6)

44.8 (65.1)

Propionate

1.25 (0.54)

1.71 (1.48)

Butyrate

0.68 (0.50)

0.71 (0.99)

Formate

18.9 (6.96)

23.9 (11.1)

Valerate

0.063 (0.044)

0.11 (0.18)

α-methylbutyrate

0.15 (0.040)

0.19 (0.11)

Isovalerate

0.50 (0.26)

0.55 (0.25)

Isobutyrate

0.29 (0.065)

0.32 (0.23)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us